Next Generation Sequencing (NGS) Market Size, Trends, Growth & Outlook

Next Generation Sequencing (NGS) Market by Product (Consumables, Platforms, and Services) Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, and Other Technologies), and End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, and Other End User): Global Opportunity Analysis and Industry Forecast, 2019–2026

Industry: Life Science | Report ID: FAMI-0031 | Published on: Sep, 2019 | View: 1450 | Share:         

Request Sample Enquire Before Buying Request Discount

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

 The global next generation sequencing market size was valued at $4,533 million in 2018, and is estimated to reach $18,565 million by 2026, growing at a CAGR of 19.2% from 2019 to 2026.

Next generation sequencing (NGS) is a novel procedure for sequencing genomes at low costs and high speed with improved efficiency. NGS also known as deep sequencing and parallel sequencing is a technology that has revolutionized molecular biology and genomics research. It is a high throughput, non-Sanger based sequencing method. Next generation sequencing has made sequencing of genomes very rapid and cost-effective. Through this method, billions of DNA strands can be sequenced efficiently. Next generation sequencing has made it possible to conveniently sequence whole genomes, and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. Next generation sequencing can be utilized through varied interventions such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.

Technological advancements in sequencing platforms, surge in applications of next generation sequencing, and increase in genome mapping programs drive the growth of the global next generation sequencing market. In addition, rise in awareness pertaining to next generation sequencing and increase in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitation related to next generation sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, use of cloud computing as a potential data management service and untapped emerging economies offer lucrative opportunities for the market players.

The next generation sequencing market is segmented based on product, application, technology, end user, and region. Based on product, the market is divided into consumables, platforms, and services. The consumables product segment is further bifurcated as sample preparation consumables and other consumables. The sample preparation consumables are further segmented into DNA fragmentation, end repair, A-Tailing & size selection, library preparation & target enrichment, and quality control. The platform NGS product segment is classified into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel System, and other sequencing platforms. The services segment is divided into sequencing services and data management services. The sequencing services is further divided into RNA Sequencing, Whole Exome Sequencing, Whole Genome Sequencing, Targeted Sequencing, Chip Sequencing, De Novo Sequencing, and Methyl Sequencing. The data management services further divided into NGS data analysis services, NGS data analysis software & workbenches, and NGS storage, management & cloud computing solutions. Based on application, the market is divided into diagnostics, biomarkers and cancer, reproductive health, personalized medicine, agriculture and animal research, other applications. By Technology, market is segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. Depends on end user, market is categorized into academic & clinical research centers, pharmaceutical & biotechnology companies, hospitals & clinics, and other end user. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the next generation sequencing market in 2015, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to higher buying power, availability, and applications that favor the utilization of NGS in this region. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize NGS in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, available disposable income, and rapidly developing economic conditions.

Product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global next generation sequencing market.

KEY MARKET BENEFITS

• The study provides an in-depth analysis of the global next generation sequencing market along with the current trends and future estimations to elucidate the imminent investment pockets.
• The report presents quantitative analysis of the market for the period of 2014–2022 to enable stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the market based on product type assists in understanding the trends in the industry.
• Key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry

KEY MARKET SEGMENTS

• By Product 

o Consumables
 Sample Preparation Consumables
• DNA Fragmentation, End Repair, A-Tailing and Size Selection
• Library Preparation & Target Enrichment
• Quality Control
 Other Consumables
o Platforms
 HiSeq
 MiSeq
 Ion Torrent
 SOLiD
 Pacbio Rs II and Sequel System
 Other Sequencing Platforms

o Services

 Sequencing Services
• RNA Sequencing
• Whole Exome Sequencing
• Whole Genome Sequencing
• Targeted Sequencing
• Chip Sequencing
• De Novo Sequencing
• Methyl Sequencing

 Data Management Services

• NGS Data Analysis Services
• NGS Data Analysis Software & Workbenches
• NGS Storage, Management and Cloud Computing Solutions

• By Application

o Diagnostics
o Biomarkers and Cancer
o Reproductive Health
o Personalized Medicine
o Agriculture and Animal Research
o Other Applications

• By Technology

o Sequencing by Synthesis
o Ion Semiconductor Sequencing
o Sequencing by Ligation
o Pyrosequencing
o Single Molecule Real Time Sequencing
o Other Technologies

• By End User 

o Academic and Clinical Research Centers
o Pharmaceutical and Biotechnology Companies
o Hospitals and Clinics
o Other End User

• By Region

o North America
 U.S.
 Canada
 Mexico
o Europe
 Germany
 France
 UK
 Italy
 Spain
 Rest of Europe
o Asia-Pacific
 Japan
 China
 Australia
 India
 South Korea
 Taiwan
 Rest of Asia-Pacific
o LAMEA
 Brazil
 Turkey
 Saudi Arabia
 South Africa
 Rest of LAMEA


KEY PLAYERS PROFILED

• Illumina, Inc. 
• Thermo Fisher Scientific, Inc.
• Pacific Biosciences of California, Inc.
• Beijing Genomics Institute
• Qiagen N.V. 
• 454 Life Sciences Corporation (Roche Holding AG)
• Agilent Technologies, Inc.
• Perkinelmer, Inc.
• Genomatix GmbH 
• PierianDx

Other players in the value chain include (profiles not included in the report)

• Eurofins Scientific
• Gatc Biotech AG
• Macrogen, Inc.
• Oxford Nanopore Technologies, Ltd.
• Bio-Rad Laboratories, Inc.
• DNASTAR, Inc.
• Biomatters Ltd.
• Partek Inc.
• New England Biolabs, Inc. 
• Myriad Genetics, Inc.

Get a sample pages of this report Click here

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments
1.4.    Research methodology

1.4.1.    Primary research
1.4.2.    Secondary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    CXO perspective
2.2.    Key findings

2.2.1.    Top impacting factors
2.2.2.    Top investment pockets

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Parent Market Overview
3.3.    Key Forces Shaping Next generation sequencing Market

3.3.1.    Moderate bargaining power of suppliers
3.3.2.    Low threat of new entrants
3.3.3.    Low threat of substitutes
3.3.4.    Moderate intensity of rivalry
3.3.5.    High bargaining power of buyers

3.4.    Pricing Analysis

3.4.1.    Pricing Analysis, By Region, 2018 & 2026

3.5.    Market Evolution
3.6.    Value Chain Analysis
3.7.    Impact of Government Regulations on Global Next Generation Sequencing Market
3.8.    Patent Analysis (2016-2018)

3.8.1.    Patent Analysis, by Year
3.8.2.    By Country
3.8.3.    By Applicant

3.9.    Case Studies

3.9.1.    Case Study 01

3.10.    Market dynamics

3.10.1.    Drivers

3.10.1.1.    Technological advancements in NGS
3.10.1.2.    Surge in applications of NGS
3.10.1.3.    Increase in partnerships and collaborations
3.10.1.4.    Increase in genome mapping programs

3.10.2.    Restraints

3.10.2.1.    Standardization concerns over NGS based diagnostics
3.10.2.2.    Lack of skilled professionals
3.10.2.3.    Ethical and legal limitations

3.10.3.    Opportunities

3.10.3.1.    Lucrative opportunities in emerging markets
3.10.3.2.    Cloud computing: potential data management service

CHAPTER 4:    NEXT GENERATION SEQUENCING MARKET, BY PRODUCT

4.1.    Overview
4.2.    Market size and forecast
4.3.    Consumables

4.3.1.    Key market trends, growth factors and opportunities
4.3.2.    Market size and forecast, by type

4.3.2.1.    Sample preparation consumables

4.3.2.1.1.    Market size and forecast, by type

4.3.2.1.1.1.    DNA Fragmentation, End Repair, A-Tailing and Size Selection

4.3.2.1.1.1.1.    Market size and forecast

4.3.2.1.1.2.    Library preparation & target enrichment

4.3.2.1.1.2.1.    Market size and forecast

4.3.2.1.1.3.    Quality Control

4.3.2.1.1.3.1.    Market size and forecast

4.3.2.2.    Other Consumables

4.3.2.2.1.    Market size and forecast

4.3.3.    Market size and forecast, by region
4.3.4.    Market analysis by country

4.4.    Platforms

4.4.1.    Key market trends, growth factors, and opportunities
4.4.2.    Market size and forecast, by type

4.4.2.1.    HiSeq series

4.4.2.1.1.    Market size and forecast

4.4.2.2.    MiSeq series

4.4.2.2.1.    Market size and forecast

4.4.2.3.    ION Torrent

4.4.2.3.1.    Market size and forecast

4.4.2.4.    SOLiD

4.4.2.4.1.    Market size and forecast

4.4.2.5.    Pacbio Rs II and Sequel system

4.4.2.5.1.    Market size and forecast

4.4.2.6.    Other Sequencing Platforms

4.4.2.6.1.    Market size and forecast

4.4.3.    Market size and forecast, by region
4.4.4.    Market analysis by country

4.5.    Services

4.5.1.    Key market trends, growth factors and opportunities
4.5.2.    Market size and forecast, by type

4.5.2.1.    Sequencing Services

4.5.2.1.1.    Market size and forecast, by type

4.5.2.1.1.1.    RNA Sequencing

4.5.2.1.1.1.1.    Market size and forecast

4.5.2.1.1.2.    Whole exome sequencing

4.5.2.1.1.2.1.    Market size and forecast

4.5.2.1.1.3.    Whole genome sequencing

4.5.2.1.1.3.1.    Market size and forecast

4.5.2.1.1.4.    Targeted sequencing

4.5.2.1.1.4.1.    Market size and forecast

4.5.2.1.1.5.    Chip sequencing

4.5.2.1.1.5.1.    Market size and forecast

4.5.2.1.1.6.    De Novo sequencing

4.5.2.1.1.6.1.    Market size and forecast

4.5.2.1.1.7.    Methyl sequencing

4.5.2.1.1.7.1.    Market size and forecast

4.5.2.2.    Data management services

4.5.2.2.1.    Market size and forecast, by type

4.5.2.2.1.1.    NGS Data Analysis Services

4.5.2.2.1.1.1.    Market size and forecast

4.5.2.2.1.2.    NGS data analysis software & workbenches

4.5.2.2.1.2.1.    Market size and forecast

4.5.2.2.1.3.    NGS storage, management, and cloud computing solutions

4.5.2.2.1.3.1.    Market size and forecast

4.5.3.    Market size and forecast, by region
4.5.4.    Market analysis by country

CHAPTER 5:    NEXT GENERATION SEQUENCING MARKET, BY APPLICATION

5.1.    Overview
5.2.    Market size and forecast
5.3.    Biomarkers and Cancer

5.3.1.    Market size and forecast, by region
5.3.2.    Market analysis by country

5.4.    Diagnostics

5.4.1.    Market size and forecast, by region
5.4.2.    Market analysis by country

5.5.    Reproductive Health

5.5.1.    Market size and forecast, by region
5.5.2.    Market analysis by country

5.6.    Personalized Medicine

5.6.1.    Market size and forecast, by region
5.6.2.    Market analysis by country

5.7.    Agriculture and Animal Research

5.7.1.    Market size and forecast, by region
5.7.2.    Market analysis by country

5.8.    Other Applications

5.8.1.    Market size and forecast, by region
5.8.2.    Market analysis by country

CHAPTER 6:    NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY

6.1.    Overview
6.2.    Market size and forecast
6.3.    Sequencing by Synthesis (SBS)

6.3.1.    Market size and forecast, by region
6.3.2.    Market analysis by country

6.4.    Ion Semiconductor Sequencing (IOS)

6.4.1.    Market size and forecast, by region
6.4.2.    Market analysis by country

6.5.    Sequencing by Ligation (SBL)

6.5.1.    Market size and forecast, by region
6.5.2.    Market analysis by country

6.6.    Pyrosequencing

6.6.1.    Market size and forecast, by region
6.6.2.    Market analysis by country

6.7.    Single-Molecule-Real-Time Sequencing (SMRT)

6.7.1.    Market size and forecast, by region
6.7.2.    Market analysis by country

6.8.    Other Technologies

6.8.1.    Market size and forecast, by region

Select License Type
  • Single User License $5370 USD
  • Multi-User License $6450 USD
  • Corporate User License $8995 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.